BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 12, 2003
View Archived Issues
Once-monthly octreotide acetate improves visual acuity in cystoid macular edema
Read More
Antiviral and antiinflammatory effects for N-chlorotaurine in adenoviral keratoconjunctivitis
Read More
Tripep to acquire Isconova
Read More
Development of CEL-1000 for herpes simplex funded by NIAID
Read More
Initiation of phase I clinical trial of TTS-CD3 in patients with NSCLC
Read More
PDL discontinues development of anti-IL-4 antibody for asthma
Read More
NeoPharm granted FDA permission for LEP-ETU clinical trial
Read More
Xcyte T-cell product enters phase I/II trial in multiple myeloma
Read More
Abgenix and Sosei enter CRTH2-targeting antibody development agreement
Read More
Genentech and ABC(2) to collaborate on Tarceva brain cancer trial
Read More
Dendreon uses telomerase in new cancer immunotherapy
Read More
Emisphere's oral insulin candidate enters clinical testing
Read More
Vancomycin-cephalosporin conjugates prepared and tested at Theravance
Read More
Roche describes another series of adenosine A2A receptor modulators
Read More
Tularik reports IRAK inhibitors and their use in inflammatory, proliferative and immune disorders
Read More
Dual 5-HT reuptake inhibitors/5-HT1A agonists described in Wyeth patent
Read More
Novel H3 receptor modulators designed by Novo Nordisk and Boehringer Ingelheim team
Read More
Debio presents new camptothecin prodrugs in recent patent
Read More
New PDE5 inhibitors under study at Merck KGaA
Read More
Enanta claims new ciclosporin analogues with utility in asthma therapy
Read More
Pharmacia (now Pfizer) presents new 5-HT6 receptor ligands
Read More
Novartis scientists discover novel steryl sulfatase inhibitors for acne, hirsutism, etc.
Read More
Cozaar approved for diabetics with kidney disease and high blood pressure in Canada
Read More
Chugai research operations to close in U.S.
Read More
Second Merck antibody advances to phase II trials
Read More
Licensing opportunity from Milkhaus: ML-04 for BPH and prostatitis
Read More
Multivalent Fab molecule targeting ICAM-1 prevents HRV infection
Read More
SUN-C8079, a new NF-kB inhibitor, evaluated in vitro and in vivo
Read More
New antibacterial agent activated by L-tryptophanase, a bacteria-specific enzyme
Read More